DUO RUI PHARMA: The company's control may change, and trading will be suspended starting September 29
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, DUO RUI PHARMA announced that its controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd. (referred to as "Tibet Jiakang"), and the actual controller, Mr. Deng Yong, are planning matters related to the change of control of the company, which may lead to a change in the company's controlling shareholder and actual controller. The company's stock will be suspended from trading starting from the morning of September 29, 2025 (Monday), and the suspension is expected to last no more than 2 trading days
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments